Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0001012975-21-000206
Filing Date
2021-05-14
Accepted
2021-05-14 16:09:13
Documents
1
Period of Report
2021-03-31
Effectiveness Date
2021-05-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 1925
  Complete submission text file 0001012975-21-000206.txt   3013
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (415) 697-1002
Pivotal bioVenture Partners Fund I U.G.P., Ltd (Filer) CIK: 0001752847 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-20631 | Film No.: 21924627